Sep 08, 2021 / 05:25PM GMT
Neena Marie Bitritto-Garg - Citigroup Inc., Research Division - VP & Analyst
So good afternoon or good morning for those on the West Coast. Thanks for joining Citi's 16th Annual Biopharma Conference. I'm Neena Bitritto-Garg. I am one of the biotech analysts here at Citi, if you don't know me. And I'm really pleased to be joined for our next fireside chat by Murdo Gordon, the Executive Vice President of Global Commercial Operations at Amgen. And so today, we're going to be talking a little bit about kind of Amgen's commercial outlook as well as some higher-level topics within the biotech space and if you kind of ask that specific questions as well.
And before we get into the discussion, I just wanted to note that if anybody listening does have any questions, you can feel free to e-mail me directly or you can submit questions to the online portal, and I will incorporate them into the discussion, if time permits. So now I just wanted to turn it over to Murdo to kind of give some opening remarks.
Murdo Gordon - Amgen Inc. - Executive VP of Global
Amgen Inc at Citi BioPharma Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot